4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-044506
President and CEO sold 21,120 shares at an average $56.89 ($1,201,595)
- President and CEO acquired 100,000 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2026-04-14 | Sale 10b5-1 | −6,548 | $59.03 | $386,553 | 31,572 | I |
| BENDHEIM JACK President and CEO | 2026-04-14 | Sale 10b5-1 | −492 | $59.69 | $29,369 | 31,080 | I |
| BENDHEIM JACK President and CEO | 2026-04-15 | Sale 10b5-1 | −2,623 | $56.27 | $147,594 | 28,457 | I |
| BENDHEIM JACK President and CEO | 2026-04-15 | Sale 10b5-1 | −3,618 | $57.21 | $206,985 | 24,839 | I |
| BENDHEIM JACK President and CEO | 2026-04-15 | Sale 10b5-1 | −799 | $58.11 | $46,432 | 24,040 | I |
| BENDHEIM JACK President and CEO | 2026-04-16 | Conversion 10b5-1 | +100,000 | 124,040 | I | ||
| BENDHEIM JACK President and CEO | 2026-04-16 | Sale 10b5-1 | −5,190 | $54.56 | $283,141 | 118,850 | I |
| BENDHEIM JACK President and CEO | 2026-04-16 | Sale 10b5-1 | −1,850 | $54.88 | $101,520 | 117,000 | I |
| Derivatives | |||||||
| BENDHEIM JACK President and CEO | 2026-04-16 | Conversion · Class B Common Stock 10b5-1 | −100,000 | 19,496,034 | I | ||
| Open-market sales · 21,120 sh · avg $56.89 · $1,201,595 | |||||||
Loading xslF345X06/tm2611963-1_4seq1.xml…